These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 27666873)
1. Enhancement of the topical tolnaftate delivery for the treatment of tinea pedis via provesicular gel systems. AbouSamra MM; Salama AH J Liposome Res; 2017 Dec; 27(4):324-334. PubMed ID: 27666873 [TBL] [Abstract][Full Text] [Related]
2. Study of tolnaftate release from fatty acids containing ointment and penetration into human skin ex vivo. Kezutyte T; Drevinskas T; Maruska A; Rimdeika R; Briedis V Acta Pol Pharm; 2011; 68(6):965-73. PubMed ID: 22125963 [TBL] [Abstract][Full Text] [Related]
3. [Therapeutic efficacy of a topical tolnaftate preparation in guinea pig model of tinea pedis]. Yamaguchi H; Uchida K; Tanaka T; Yamaguchi T Jpn J Antibiot; 2001 Jun; 54(6):323-30. PubMed ID: 11521512 [TBL] [Abstract][Full Text] [Related]
4. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation. Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957 [TBL] [Abstract][Full Text] [Related]
5. D-optimal experimental approach for designing topical microemulsion of itraconazole: Characterization and evaluation of antifungal efficacy against a standardized Tinea pedis infection model in Wistar rats. Kumar N; Shishu Eur J Pharm Sci; 2015 Jan; 67():97-112. PubMed ID: 25445834 [TBL] [Abstract][Full Text] [Related]
6. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity. Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502 [TBL] [Abstract][Full Text] [Related]
7. Statistically designed nonionic surfactant vesicles for dermal delivery of itraconazole: characterization and in vivo evaluation using a standardized Tinea pedis infection model. Kumar N; Goindi S Int J Pharm; 2014 Sep; 472(1-2):224-40. PubMed ID: 24954723 [TBL] [Abstract][Full Text] [Related]
8. Elastic liposome-based gel for topical delivery of 5-fluorouracil: in vitro and in vivo investigation. Hussain A; Samad A; Ramzan M; Ahsan MN; Ur Rehman Z; Ahmad FJ Drug Deliv; 2016 May; 23(4):1115-29. PubMed ID: 25379805 [TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of proniosomes containing lornoxicam. Madan JR; Ghuge NP; Dua K Drug Deliv Transl Res; 2016 Oct; 6(5):511-8. PubMed ID: 27255375 [TBL] [Abstract][Full Text] [Related]
10. Formulation, characterization and ex vivo studies of terbinafine HCl liposomes for cutaneous delivery. Sudhakar B; Varma JN; Murthy KV Curr Drug Deliv; 2014; 11(4):521-30. PubMed ID: 24410098 [TBL] [Abstract][Full Text] [Related]
11. Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis. Korting HC; Kiencke P; Nelles S; Rychlik R Am J Clin Dermatol; 2007; 8(6):357-64. PubMed ID: 18039018 [TBL] [Abstract][Full Text] [Related]
12. Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B. Hussain A; Samad A; Singh SK; Ahsan MN; Faruk A; Ahmed FJ Drug Dev Ind Pharm; 2015 May; 41(5):780-90. PubMed ID: 24654936 [TBL] [Abstract][Full Text] [Related]
13. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226 [TBL] [Abstract][Full Text] [Related]
14. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B. Hussain A; Singh VK; Singh OP; Shafaat K; Kumar S; Ahmad FJ Drug Deliv; 2016 Oct; 23(8):3101-3110. PubMed ID: 27854145 [TBL] [Abstract][Full Text] [Related]
15. Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: formulation optimization, in vitro evaluation and preclinical assessment. Garg BJ; Garg NK; Beg S; Singh B; Katare OP J Drug Target; 2016 Mar; 24(3):233-246. PubMed ID: 26267289 [TBL] [Abstract][Full Text] [Related]
16. Provesicular elastic carriers of Simvastatin for enhanced wound healing activity: An in-vitro/in-vivo study. Abd El-Alim SH; Salama A; Darwish AB Int J Pharm; 2020 Jul; 585():119470. PubMed ID: 32464234 [TBL] [Abstract][Full Text] [Related]
17. Formulation and Evaluation of Novel Hybridized Nanovesicles for Enhancing Buccal Delivery of Ciclopirox Olamine. AbouSamra MM; Salama AH; Awad GEA; Mansy SS AAPS PharmSciTech; 2020 Oct; 21(7):283. PubMed ID: 33051708 [TBL] [Abstract][Full Text] [Related]
18. Luliconazole vesicular based gel formulations for its enhanced topical delivery. Kaur M; Singh K; Jain SK J Liposome Res; 2020 Dec; 30(4):388-406. PubMed ID: 31631734 [TBL] [Abstract][Full Text] [Related]
19. Novel diphenyl dimethyl bicarboxylate provesicular powders with enhanced hepatocurative activity: preparation, optimization, in vitro/in vivo evaluation. Aburahma MH; Abdelbary GA Int J Pharm; 2012 Jan; 422(1-2):139-50. PubMed ID: 22079716 [TBL] [Abstract][Full Text] [Related]
20. Assessing the Efficacy of Berberine Hydrochloride-loaded Transethosomal Gel System in Treating Dermatophytosis Caused by Mishra KK; Kaur CD; Singh S; Tiwari A; Tiwari V; Sharma A Curr Drug Res Rev; 2024; 16(3):412-422. PubMed ID: 37496248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]